Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,690 | -7,668 | -3,246 | -10,385 | -7,342 |
| Depreciation Amortization | 2 | 1 | 1 | 3 | 2 |
| Accounts payable and accrued liabilities | 310 | 798 | -41 | -307 | 1,068 |
| Other Working Capital | 318 | 698 | 257 | 116 | 1,581 |
| Other Operating Activity | 246 | -397 | 589 | 2,602 | 148 |
| Operating Cash Flow | $-8,814 | $-6,568 | $-2,441 | $-7,971 | $-4,542 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -2 | N/A |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-2 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 4,210 | 3,910 |
| Common Stock Issued | 8,371 | 8,371 | 6,608 | 6,117 | 0 |
| Other Financing Activity | 0 | 0 | 0 | 556 | 536 |
| Financing Cash Flow | $8,371 | $8,371 | $6,608 | $10,883 | $4,446 |
| Beginning Cash Position | 3,204 | 3,204 | 3,204 | 294 | 294 |
| End Cash Position | 2,762 | 5,008 | 7,371 | 3,204 | 199 |
| Net Cash Flow | $-442 | $1,804 | $4,167 | $2,910 | $-96 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,814 | -6,568 | -2,441 | -7,971 | -4,542 |
| Capital Expenditure | N/A | N/A | N/A | -2 | N/A |
| Free Cash Flow | -8,814 | -6,568 | -2,441 | -7,973 | -4,542 |